{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/pre-conception-advice-management/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"eea0164e-7605-53f2-82b1-30649c6b462b","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field 8be25f3b-5e30-455e-a555-004a1fe1de79 --><h2>Changes</h2><!-- end field 8be25f3b-5e30-455e-a555-004a1fe1de79 -->","summary":null,"htmlStringContent":"<!-- begin item fa451252-f623-421a-a88e-c4b4d0cead51 --><!-- begin field 04e470e6-bd39-4405-b2f2-e60cc284da04 --><p><strong>November 2019</strong> — minor update. Advise to prescribe higher dose folic acid to women with coeliac disease changed to be in line with NICE guidance.</p><p><strong>August 2019</strong> — minor update. Information in the basis for recommendation section regarding dose of folate supplementation depending on the risk of NTD was updated to add further clarity.</p><p><strong>August 2017 </strong>— reviewed. A literature search was conducted in June 2017 to identify evidence-based guidelines, UK policy, systematic reviews, and key RCTs published since the last revision of the topic. Changes to this topic include:</p><ul><li>Inclusion of information on planning the timing of pregnancy; use of prescription medicines when planning a pregnancy; and managing women who are underweight prior to conception. New sections on rheumatological conditions and inflammatory bowel disease have also been added.</li><li>Creation of a general section on mental health issues that incorporates previous information on depression, bipolar disorder, and psychosis and schizophrenia.</li><li>Minor changes to the management recommendations on alcohol advice; managing a woman with diabetes planning to conceive; referral of women with asthma for preconception assessment and advice; and recommendations on genetic risk assessment.</li></ul><!-- end field 04e470e6-bd39-4405-b2f2-e60cc284da04 --><!-- end item fa451252-f623-421a-a88e-c4b4d0cead51 -->","topic":{"id":"7fbac536-1f76-5678-a8d3-791cde12bdcc","topicId":"362122fc-a8d4-48c6-bbe1-260b84fdc035","topicName":"Pre-conception - advice and management","slug":"pre-conception-advice-management","lastRevised":"Last revised in November 2019","chapters":[{"id":"b4e662d9-e04d-5220-9289-f9d2f83a655d","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"d516f1b7-0d03-56d1-a1ff-98ee4586d10c","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"05f2e291-0cb3-508a-a53a-203bf7452154","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"eea0164e-7605-53f2-82b1-30649c6b462b","slug":"changes","fullItemName":"Changes"},{"id":"3107f6a6-010e-5793-b49e-f188321b5d25","slug":"update","fullItemName":"Update"}]},{"id":"ccdc8c20-befb-5b1b-9e44-e7d66512c304","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"d2c77d6a-aa8b-5f5a-bc22-e802a1ed63dd","slug":"goals","fullItemName":"Goals"},{"id":"354ac657-195c-55c7-86dc-32bd495719e6","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"90c0a8b7-d685-5b54-ab19-50262a840059","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"8991e1d6-fe99-54e2-a7f0-8c087cbc913e","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"ce6a54cd-7770-5f7d-b3d4-72d82e13e288","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"cea8adf5-cc1a-59e9-b1bc-a7fe7dd9612e","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"8ebfaff6-f12e-5e6d-a4da-824f9755cc22","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"eb257b56-0f26-5b88-b016-779a5c57372a","slug":"definition","fullItemName":"Definition"}]},{"id":"cb07c890-793e-585a-b84c-853632ed27ce","fullItemName":"Management","slug":"management","subChapters":[{"id":"bd42d278-6050-5b5b-866a-cbfbf0423199","slug":"assessment","fullItemName":"Scenario: Assessment"},{"id":"eb9c8dbd-e2aa-5e1d-ad75-0f16e58a1422","slug":"advice-for-all-women","fullItemName":"Scenario: Advice for all women"},{"id":"7e7545d6-d6f7-57bc-89ea-6441a4ec2db1","slug":"mental-health-problems","fullItemName":"Scenario: Mental health problems"},{"id":"1a2f1279-2d58-50c7-9319-7566398adf95","slug":"chronic-medical-conditions","fullItemName":"Scenario: Chronic medical conditions"},{"id":"06434a48-ae53-5381-a6e0-d1d478bf119e","slug":"genetic-risk-assessment","fullItemName":"Scenario: Genetic risk assessment"}]},{"id":"09ba2cc8-ed92-569e-8221-2fc8961a9165","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"5d207bb7-2d21-5faf-8689-655bc58b847f","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"5c10ffbd-047a-5920-9dc4-cfc597cebbad","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"aaed13a3-4796-527d-97c1-0d3f0522735c","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d4f44dbc-1899-520a-af01-19a4c31b4859","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"78c00268-d8ca-507c-b64e-d937902ec290","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"8a776444-784a-5839-9597-61faaeeb2101","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"6a3cee62-2ded-5f48-b3fc-9b11a7a28a12","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"05f2e291-0cb3-508a-a53a-203bf7452154","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"97460093-dbca-5c64-a9dd-9f3c6d6d3277","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field ebb3588e-ef1f-4644-92df-a4505f64fa64 --><h3>Previous changes</h3><!-- end field ebb3588e-ef1f-4644-92df-a4505f64fa64 -->","summary":null,"htmlStringContent":"<!-- begin item 239fa998-1590-4882-b11c-77de7bcfe8a7 --><!-- begin field 08d794ec-12d5-41e0-9e77-dfaca99db785 --><p><strong>September 2016 </strong>— minor update. Advice relating to Zika virus was added and updated in the management scenarios.</p><p><strong>March 2012 </strong>— revised. A literature search was conducted in January 2012 to identify evidence-based guidelines, UK policy, systematic reviews, and key RCTs published since the last revision of the topic. Minor changes to clinical recommendations have been made.</p><p><strong>January 2012 </strong>— minor update. Reference to the 2004 National Institute for Health and Care Excellence (NICE) guideline The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care has been changed to reflect the updated NICE guideline.</p><p><strong>March 2011 </strong>— topic structure revised to ensure consistency across CKS topics — no changes to clinical recommendations have been made.</p><p><strong>March 2011 </strong>— minor update. Text added regarding the small increased risk of cardiovascular malformation associated with first trimester maternal exposure to fluoxetine. Issued in June 2011.</p><p><strong>September 2010 </strong>— minor update. Text amended to include recommendations from the National Institute for Health and Care Excellence (NICE) public health guidance 27 about preparing for pregnancy for women with a body mass index (BMI) of 30 kg/m<sup>2 </sup>or more. Issued September 2010.</p><p><strong>January 2009 </strong>— minor update to clarify the advice for folic acid supplementation in women with sickle-cell anaemia and thalassaemia. Issued in February 2009.</p><p><strong>August 2007 </strong>— minor typographical updates to the Clinical Summaries (<em>Advice for all women</em>, <em>Women with chronic medical conditions</em>, <em>Women with mental health issues</em>, and <em>Women with metabolic disorders</em>). Issued in August 2007.</p><p><strong>April to July 2007 </strong>— converted from CKS guidance to CKS topic structure. The evidence-base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence. Updated alcohol advice for pregnant women issued by the Department of Health has been included.</p><p><strong>March 2007 </strong>— minor update to include recent national guideline advice regarding the management of women with hypothyroidism and sub-clinical hypothyroidism who are planning a pregnancy or have pregnancy confirmed <em>BTA et al, 2006</em>. Issued in March 2007.</p><p><strong>January 2007 </strong>— minor update to include advice to screen women for hepatitis B, syphilis, and HIV (in line with standard UK antenatal care). Issued in January 2007.</p><p><strong>October 2006 </strong>— minor update to include recent advice form CEMACH, recommending folic acid 5 mg for diabetic women who wish to become pregnant. Minor update to include Department of Health advice regarding immunization with varicella vaccine for health care workers. Issued in October 2006.</p><p><strong>January 2006 </strong>— minor update to include recent advice from the MHRA regarding the safety of paroxetine in pregnancy. Issued in February 2006.</p><p><strong>December 2003 </strong>— written. Validated in March 2004 and issued in June 2004.</p><!-- end field 08d794ec-12d5-41e0-9e77-dfaca99db785 --><!-- end item 239fa998-1590-4882-b11c-77de7bcfe8a7 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}